Quantitative testing platform for soft tissue mechanics
Xijian Technology is the world's first soft tissue mechanics quantitative testing device, which is based on non-invasive mechanical quantitative testing scenarios of soft tissue in vivo. It performs mechanical quantitative testing on muscles and tendons in multiple dimensions such as structure, performance, and function.
Biomimetic phantom series products
It is poured with a new generation of green and environment-friendly hydrogel, and its physical and chemical properties are close to real human tissues
Customization and simulation of various human tissues such as tumors, blood vessels, nerves, stones, etc
About Us ●•
Beijing Xijian Technology Co., Ltd. is based on more than ten years of research foundation in the field of human soft tissue mechanics characterization in the Biomaterials and Soft Materials Mechanics Laboratory of Tsinghua University. It is committed to promoting the industrialization of quantitative platform technology in human biomechanics.
Founded
+
Intellectual Property Rights
+
Publications
Incubation period of the company (2021-2022)
In October 2021, Xijian Technology was officially established, with its core technology originating from the research group led by Prof. Cao Yanping at Tsinghua University's Institute of Biomechanics and Medical Engineering. Closed Angel and Pre-A rounds (2021–2022).
Product Development and Clinical Validation Period (2023)
Xijian Technology reached a formal cooperation agreement with the National Clinical Research Center for Orthopedics and Sports Rehabilitation; completed development of its original musculoskeletal biomechanics quantification device and initiated NMPA medical-device registration; closed Pre-A+ round.
Commercial growth period (2024-2026)
Launched the first NMPA Class II medical-device production line; received the first NMPA registration certificate, leading the field of musculoskeletal biomechanics quantification; rapidly expanded into medical aesthetics and veterinary medicine; closed Series A financing.
Products ●•
Committed to industrializing original innovations in quantitative biomechanics platform technology
 |
Soft tissue mechanics quantitative testing platform |
 |
Biomimetic phantom series products
|
Quantitative testing platform for soft tissue mechanics
Product positioning: Quantitative biomechanics platform for research and clinical applications in tertiary hospitals
Product function: in-vivo, non-invasive, rapid, quantitative measurement of shear modulus, passive stress, and active stress in superficial soft tissues
Target customers: Rehabilitation, Professional Sports, Traditional Chinese Medicine, Orthopedics
Indications: anterior knee pain, patellofemoral instability, shoulder and neck pain, tenosynovitis, sarcopenia, scoliosis, lymphedema, dystonia, and exercise-related muscle fatigue
Biomimetic phantom series products
It is poured with a new generation of green environmental protection hydrogel, and its physical and chemical properties are close to real human tissues for customization and simulation of tumors, blood vessels, nerves, stones and other human tissues
Widely applied in fields such as ultrasound specialized skill training, clinical basic skill training, tumor ablation training, and clinical medical research practice.
Application Direction ●•
Committed to promoting the industrialization of human biomechanics quantitative platform technology and providing the world's leading human soft tissue mechanics quantitative platform for the industry.
Professional Medical Applications
Clinical-grade applications widely deployed across orthopedics, rehabilitation, sports medicine, geriatrics, traditional Chinese medicine, oncology, neurology, and pain medicine.
Consumer Healthcare
Targeting consumer-medical channels — sports training, traditional Chinese medicine, massage therapy, pet medicine, medical aesthetics — to drive standardized adoption and shared definitions of quantitative biomechanics.
Consumer Health
Personalized muscle assessment and training guidance for sports and fitness enthusiasts; in-home skin-elasticity monitoring for medical-aesthetics consumers.
R&D Capability ●•
Based on more than ten years of research foundation in the field of human soft tissue mechanics characterization in the Laboratory of Biomaterials and Soft Materials Mechanics at Tsinghua University, Xijian Technology has developed a quantitative platform technology for soft tissue mechanics by combining clinical and consumer market needs. The company has strong scientific research capabilities, with a research team leading 6 National Natural Science Foundation projects and publishing over 160 SCI papers. The papers have been cited over 5400 times and have an H-index of 37.
Scientific Research Collaboration ●•
Xijian Technology builds a systematic clinical research and services system, covering every stage of research projects and providing tailored application support for researchers.
Collaborated Units:
- Rehabilitation Department of a tertiary hospital in Beijing
- School of Physical Education at a university in Beijing
- Department of Dermatology of a tertiary hospital in Beijing
News Center ●•
Committed to promoting the industrialization of quantitative platform technology in human biomechanics
-
Recently,Director Xiao Jing's team from the Rehabilitation Medicine Department of Xiyuan Hospital, Chinese Academy of Chinese Medical SciencesA clinical research paper entitled "Evaluation of the effect of acupotomy on trapezius myofascial pain syndrome based on shear wave elastography" was published on the authoritative Chinese medicine journal acupuncture and moxibustion.This study was conducted by the Rehabilitation Medicine Department of Xiyuan HospitalDr. Rao YiAs the first author,Xijian TechnologyThe portable shear wave elastography (pSWE) device provided serves as the core evaluation tool, covering the entire process of clinical data collection. This study not only validates the effectiveness of needle knife therapy, but also marks a milestoneThe portable shear wave elastography technology has taken a solid step towards the objective and quantita... -
From November 14th to 16th,The 2025 Fujian Pain Professional Quality Control Center Study Class, Fujian Medical Association Pain Physician Branch Annual Meeting, and Chronic Pain Diagnosis and Treatment New Progress Study Class were successfully held in Fuzhou.The conference brought together renowned experts and scholars in the field of pain medicine from within and outside the province to engage in thematic exchanges on the cutting-edge progress and clinical practice of pain diagnosis and treatment, sharing wisdom and experience, and inspiring innovation and thinking.This conference has received widespread attention and support from the industry, attracting experts, scholars, and professionals from all over the country to participate. The conference aims to explore the latest developments and hot issues in the industry through expert lectures, academic exc...
-
On November 13, 2025, the 14th China Innovation and Entrepreneurship Competition Biomedical National Competition successfully concluded in Haikou, Hainan. Since its launch, this competition has attracted nearly30000 enterprisesRegistration, after layers of selection by competition area, finally228 projectsNominated for the national competition, only20 projectsNominated for the finals.With its core technological advantages and industrialization potential, Xijian Technology has successfully advanced to the semi-finals and finals, and won the "Excellent Enterprise Award" of this competition.The China Innovation and Entrepreneurship Competition is one of the longest, largest, and most influential events in China. Since its establishment in 2012, it has been held for fourteen consecutive sessions. The competition adheres to the principle of "government guidance, p...
